In a dramatic turn of events, Dr Imraan Shaikh recants his previous findings regarding Zurenah Smit's medical condition ...

Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges ...

Bayers experimental stroke treatment, asundexian, delivered strong results in the Phase III OCEANIC-STROKE trial, prompting ...

A research paper by scientists at the Capital Medical University evaluated sex differences in stroke recurrence among ...

Bayer Sunday announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian.The study met its primary efficacy ...

Bayer reported a major boost to its drug pipeline on Monday morning, after its experimental anticoagulant asundexian delivered positive results in a large phase three trial, easing concerns following ...

Investing.com -- Bayer’s (ETR:BAYGN) experimental stroke drug could generate €3 billion in annual sales after successful trial results that Goldman Sachs analyst James Quigley called "transformational ...

Donald Glover shared insight into his 2024 health scare that forced him to cancel his Childish Gambino tour, confirming a ...

The 42-year-old performer - real name Donald Glover - has spoken out about his health scare at Camp Flog Gnaw Festival over ...

An international study led by Mayo Clinic researchers has found that for people with severe carotid artery narrowing who ...

Bayer today announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian. The study met its primary efficacy ...

Approximately 90,000 people in the UK survive a stroke each year — a stark reality that Donald Glover has now also confronted ...